Edwards Lifesciences

Edwards Lifesciences is a manufacturer and supplier of medical equipment such as artificial heart valves and hemodynamic monitoring devices. Read more

9,971 Followers on Owler
9,971 Followers on Owler
9,971 Followers on Owler
9,971 Followers on Owler

Edwards Lifesciences

Edwards Lifesciences is a manufacturer and supplier of medical equipment such as artificial heart valves and hemodynamic monitoring devices. Read more

Michael A. Mussallem's photo - Chairman & CEO of Edwards Lifesciences

Chairman & CEO

Michael A. Mussallem

CEO Approval Rating

75/100

Founded:

1958

Status:

PublicIndependent CompanyNYSEEW

EDWARDS LIFESCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Medtronic is perceived as one of Edwards Lifesciences's biggest rivals. Medtronic was founded in 1949, and is headquartered in Minneapolis, Minnesota. Like Edwards Lifesciences, Medtronic also competes in the Health Care Equipment space. Medtronic generates $23.5B more revenue vs. Edwards Lifesciences.

Boston Scientific is a top competitor of Edwards Lifesciences. Boston Scientific is a Public company that was founded in 1979 in Marlborough, Massachusetts. Like Edwards Lifesciences, Boston Scientific also works within the Health Care Equipment sector. Compared to Edwards Lifesciences, Boston Scientific has 25,200 more employees.

Abbott is Edwards Lifesciences's #3 rival. Abbott is headquartered in Abbott Park, Illinois, and was founded in 1888. Abbott operates in the Health Care Equipment industry. Abbott generates 851% the revenue of Edwards Lifesciences.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is ICU Medical a competitor of Edwards Lifesciences?

Edwards Lifesciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$4.4B

Edwards Lifesciences's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 8.3B. Over the last four quarters, Edwards Lifesciences's revenue has grown by 31.5%. Specifically, in Q1 2021's revenue was $1.2B; in Q4 2020, it was $1.2B; in Q3 2020, it was $1.1B; in Q2 2020, Edwards Lifesciences's revenue was $925M.

Edwards Lifesciences Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Cas Medical Systems Inc

Feb 2019

Source »
$100M
FORE-SIGHT designs and manufactures cerebral oximetry devices for monitoring and measuring tissue oxygenation in the brain.
Harpoon Medical, Inc.

Dec 2017

Source »
$100M
Harpoon is a medical technology company that engages in developing therapeutic solutions for patients with mitral valve disease.
Valtech Cardio, Ltd.

Nov 2016

Source »
$340M
Valtech specializes in the development of surgical and transcatheter valve repair and replacement devices for the treatment of heart valve diseases.
CardiAQ Valve Technologies, Inc.

Jul 2015

Source »
$350M
CardiAQ develops a proprietary system for heart transcatheter mitral valve implantation.

-

Embrella Cardiovascular

Mar 2011

Source »
$43M
-

These are all the companies that Edwards Lifesciences has acquired. Edwards Lifesciences has acquired 6 companies and its latest acquisition was Cas Medical Systems Inc in Feb 2019. FORE-SIGHT designs and manufactures cerebral oximetry devices for monitoring and measuring tissue oxygenation in the brain.

Edwards Lifesciences Funding History

Since Edwards Lifesciences was founded in 1958, it has participated in 2 rounds of funding. In total Edwards Lifesciences has raised $307.2M. Edwards Lifesciences' last funding round was on May 2018 for a total of $34.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
May 2018
$34.9M
-
Equity
Jan 2017
$272.4M
-

Since Edwards Lifesciences was founded in 1958, it has participated in 2 rounds of funding. In total Edwards Lifesciences has raised $307.2M. Edwards Lifesciences' last funding round was on May 2018 for a total of $34.9M

Edwards Lifesciences Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Caption Health is a California-based developer of AI-guided ultrasound systems for physicians to diagnose heart diseases.
$53M
Jul 14, 2020
Series B
-
V-Wave is a medical device company that develops and distributes minimally invasive interatrial shunt devices for heart diseases.
$70M
Apr 25, 2018
Series C
-
V-Wave is a medical device company that develops and distributes minimally invasive interatrial shunt devices for heart diseases.
$28M
Jan 10, 2016
Series B
-
Harpoon is a medical technology company that engages in developing therapeutic solutions for patients with mitral valve disease.
-
Dec 13, 2015
Equity
Dec 01, 2017
CardioKinetix operates as a medical device firm that develops catheter-based treatment devices to treat congestive heart attack.
$50M
Dec 04, 2014
Series F
-

These are all the companies that Edwards Lifesciences has invested in. Edwards Lifesciences has invested 6 companies and its latest investment was Cas Medical Systems Inc in Feb 2019. FORE-SIGHT designs and manufactures cerebral oximetry devices for monitoring and measuring tissue oxygenation in the brain.

Edwards Lifesciences News

April 21, 2021Benzinga

Edwards Lifesciences

In the current session, Edwards Lifesciences Inc. (NYSE:EW) is trading at $93.45, after a 4.33% incre... See more »
April 20, 2021FinanzNachrichten

Edwards Lifesciences Q1 Results Beat Street View; Lifts Outlook

WASHINGTON (dpa-AFX) - Shares of Edwards Lifesciences Corp. (EW) gained nearly 4% in extended trading... See more »
April 20, 2021MarketScreener

Edwards Lifesciences Raises FY21 Profit Outlook

(marketscreener.com) By Kimberly Chin Edwards Lifesciences Inc. raised its full-year earnings outlook... See more »
April 20, 2021FinanzNachrichten

Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) released earnings for its first quarter that a... See more »
April 20, 2021Investor’s Business Daily

Edwards Lifesciences Adds To Breakout After Smashing First-Quarter Estimates

Edwards Lifesciences on Tuesday reported adjusted earnings of 54 cents per share on $1.22 billion in ... See more »
April 18, 2021Markets Insider

here's what Wall Street expects

On April 20, Edwards Lifesciences will be reporting earnings Q1.Analysts on Wall Street predict Edwar... See more »
April 13, 2021MarketScreener

To Host Earnings Conference Call On April 20, 2021

(marketscreener.com) IRVINE, Calif., April 13, 2021 /PRNewswire/ -- Edwards Lifesciences plans to ann... See more »

Edwards Lifesciences Press Releases

July 16, 2020Cision

Mentice receives order of total SEK 7.0 million from Edwards Lifesciences

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical... See more »
May 7, 2020PR Newswire

Edwards Announces Updates From Annual Meeting

IRVINE, Calif., May 7, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global l... See more »
May 5, 2020centralcharts

Edwards Lifesciences Announces May 2020 Investor Conference Schedule

Edwards Lifesciences Announces May 2020 Investor Conference Schedule PR Newswire IRVINE, Calif., May ... See more »
March 5, 2020PressReleasePoint

Edwards Lifesciences 'Hearts' Live Video Production In-House With NDI

Edwards Lifesciences is a global leader in the treatment of structural heart disease and treating of ... See more »
February 24, 2020StreetInsider

Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference

IRVINE, Calif., Feb. 24, 2020 /PRNewswire/ --Â Edwards Lifesciences Corporation (NYSE: EW), the globa... See more »
January 30, 2020StreetInsider

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., Jan. 30, 2020 /PRNewswire/ --Â Edwards Lifesciences Corporation (NYSE: EW), the globa... See more »
September 29, 2019centralcharts

Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients

Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients PR Ne... See more »

Edwards Lifesciences Videos

Social Media

Edwards Lifesciences Headquarters

One Edwards Way

Irvine, California92614

800-424-3278

Driving Directions »

Trending Companies

Edwards Lifesciences Summary

ABOUT

Overview

Edwards Lifesciences is a manufacturer and supplier of medical equipment such as artificial heart valves and hemodynamic monitoring devices. Edwards Lifesciences was founded in 1958. Edwards Lifesciences' headquarters is located in Irvine, California,...

CEO

Edwards Lifesciences's Chairman & CEO, Michael A. Mussallem, currently has an approval rating of 75%. Edwards Lifesciences's primary competitors are Medtronic, Boston Scientific & Abbott.

Website

edwards.com

Frequently Asked Questions about Edwards Lifesciences

  1. When was Edwards Lifesciences founded?

    Edwards Lifesciences was founded in 1958
  2. Who is Edwards Lifesciences's CEO?

    Edwards Lifesciences's CEO is Michael A. Mussallem
  3. How much revenue does Edwards Lifesciences generate?

    Edwards Lifesciences generates $4.4B in revenue
  4. How much funding does Edwards Lifesciences have?

    Edwards Lifesciences has historically raised $307.2M in funding
  5. Where is Edwards Lifesciences's headquarters?

    Edwards Lifesciences's headquarters is in Irvine California, USA
  1. How many employees does Edwards Lifesciences have?

    Edwards Lifesciences has 12,800 employees
  2. What sector does Edwards Lifesciences operate in?

    Edwards Lifesciences is in Health Care Equipment
  3. Who are Edwards Lifesciences's competitors?

    Edwards Lifesciences's top competitors are Medtronic, Boston Scientific, Abbott
  4. Who has Edwards Lifesciences invested in?

    Edwards Lifesciences's has invested in companies such as Caption Health, V-Wave, V-Wave